National HealthCare Corporation (NHC)
Official siteHEALTHCARE • MEDICAL CARE FACILITIES • AMEX
Market Cap: $3.26B
Last updated: Nov 17, 2026 at 4:38 PM ET
National HealthCare Corporation (NHC) Statistics
National HealthCare (NHC) has a market cap of $3.26B and an enterprise value of $3.69B. Its trailing P/E of 28.6x is above its 10-year median of 20.0x.
Total Valuation
Enterprise value is 13.36% above the market cap, as debt exceeds cash.
| Market Cap | $3.26B |
|---|---|
| Enterprise Value | $3.69B |
| Latest price (Nov 17, 2026) | $205.79 |
Key Dates
The next earnings report is expected on Feb 24, 2027, covering the quarter ending Dec 31, 2026. The next ex-dividend date is Dec 31, 2026.
| Next Earnings Date | Feb 24, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 6, 2026 |
| Next Ex-Dividend Date | Dec 31, 2026 |
| Next Payment Date | Jan 29, 2027 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 2.0x and 2.9x. Its year-end P/E ranged from 7.8x to 40.9x from 2016 to 2025.
| P/E Ratio | 28.6x |
|---|---|
| P/S Ratio | 2.0x |
| P/B Ratio | 2.9x |
| P/TBV Ratio | 3.4x |
| P/OCF Ratio | 14.7x |
Enterprise Valuation
Counting debt and cash, the company is valued at 16.6x EBITDA.
| EV / Earnings | 31.8x |
|---|---|
| EV / Sales | 2.3x |
| EV / EBITDA | 16.6x |
| EV / EBIT | 21.6x |
Price Statistics
The stock is up 62.02% over 52 weeks and trades 7.42% below its 50-day average.
| Beta (1Y) | 0.25 |
|---|---|
| 52-Week Change | +62.02% |
| 1-Month Change | -13.98% |
| 3-Month Change | -11.80% |
| 6-Month Change | +5.65% |
| 5-Year Change | +194.74% |
| 10-Year Change | +218.61% |
| Total Return (1Y) | +64.08% |
| Total Return (3Y CAGR) | +41.82% |
| Total Return (5Y CAGR) | +26.62% |
| Return vs SPY (1Y) | +54.60% |
| Max Drawdown (1Y) | -18.49% |
| Max Drawdown (3Y) | -33.40% |
| Sharpe Ratio (1Y) | 1.48 |
| Correlation with SPY (1Y) | 0.10 |
| 50-Day Average | $222.29 |
| 200-Day Average | $197.34 |
| 52-Week Range | $123.11 to $248.20 |
| RSI (14 Days) | 39.0 |
| Average Volume (20 Days) | 161.60K |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 1.48x current liabilities, and total debt is 0.45x shareholder equity.
| Current Ratio | 1.48x |
|---|---|
| Quick Ratio | 1.45x |
| Debt / Equity | 0.45x |
| Debt / EBITDA | 2.28x |
| Interest Coverage | 21.11x |
Returns and Efficiency
Return on invested capital is 8.08% over the last 12 months, against a 5-year average of 7.77%.
| Return on Equity (ROE) | 10.31% |
|---|---|
| Return on Assets (ROA) | 5.61% |
| Return on Invested Capital (ROIC) | 8.08% |
| Return on Capital Employed (ROCE) | 9.57% |
| ROE (5Y Average) | 9.35% |
| ROA (5Y Average) | 6.24% |
| ROIC (5Y Average) | 7.77% |
| Asset Turnover | 0.87x |
| Inventory Turnover | 111.92x |
| Receivables Turnover | 11.85x |
| Cash Conversion Cycle | 20 days |
Taxes
Income tax took 22.98% of pretax income over the last 12 months.
| Income Tax (TTM) | $34.62M |
|---|---|
| Effective Tax Rate | 22.98% |
Scores
NHC has an Altman Z-Score of 3.78, in the safe zone above 2.99, and a Piotroski F-Score of 8 of 9, in the strong band of 8 or 9.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 3.78 |
|---|---|
| Altman Z Zone | Safe |
| Piotroski F-Score | 8 of 9 |
| Piotroski Strength | Strong |
Income Statement
Revenue of $1.58B over the last 12 months is up 5.58% from the 12 months before.
| Revenue | $1.58B |
|---|---|
| Revenue Growth (YoY) | +5.58% |
| Gross Profit | $622.18M |
| Operating Income | $154.94M |
| Pretax Income | $150.64M |
| Net Income | $116.02M |
| EBITDA | $219.87M |
| EBIT | $170.74M |
| Reported EPS (TTM) | $7.20 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 54.11% of the $2.07B in total assets.
| Cash and Equivalents | $66.80M |
|---|---|
| Total Debt | $502.06M |
| Net Debt | $435.27M |
| Net Debt Per Share | $27.83 |
| Working Capital | $135.91M |
| Shareholder Equity | $1.12B |
| Book Value Per Share | $71.93 |
| Tangible Book Value | $934.08M |
| Tangible Book Per Share | $59.73 |
| Total Assets | $2.07B |
| Total Liabilities | $936.98M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $610.39M of capital spending, operating cash flow left -$388.63M of free cash flow.
| Operating Cash Flow | $221.76M |
|---|---|
| Capital Expenditures | $610.39M |
| Free Cash Flow | -$388.63M |
| FCF Per Share | -$24.81 |
| Depreciation and Amortization | $49.13M |
| Dividends Paid | $40.66M |
| Share Repurchases | $29.84M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is 9.78%, against a 5-year average of 5.61%.
| Gross Margin | 39.27% |
|---|---|
| Operating Margin | 9.78% |
| Pretax Margin | 9.51% |
| Net Margin | 7.32% |
| EBITDA Margin | 13.88% |
| EBIT Margin | 10.78% |
| FCF Margin | -24.53% |
| Gross Margin (5Y Average) | 37.94% |
| Operating Margin (5Y Average) | 5.61% |
| Net Margin (5Y Average) | 7.28% |
Growth
Revenue grew 11.81% a year over 3 years, and EPS 75.69% a year.
| Revenue Growth (3Y CAGR) | +11.81% |
|---|---|
| Revenue Growth (5Y CAGR) | +8.10% |
| EPS Growth (3Y CAGR) | +75.69% |
| EPS Growth (5Y CAGR) | +33.92% |
| FCF Growth (5Y CAGR) | -3.90% |
| Operating Income Growth (3Y CAGR) | +59.06% |
| Book Value Per Share Growth (2Y CAGR) | +7.89% |
| Tangible Book Per Share Growth (2Y CAGR) | +8.88% |
Dividends and Yields
NHC pays out 35.32% of earnings as dividends.
| Dividend Per Share (Annual) | $2.68 |
|---|---|
| Dividend Yield | 1.30% |
| Payment Schedule | Quarterly |
| Dividend Growth (3Y CAGR) | +3.83% |
| Dividend Growth (5Y CAGR) | +3.99% |
| Payout Ratio | 35.32% |
| Earnings Yield | 3.50% |
| FCF Yield | -12.08% |
| Buyback Yield | 0.13% |
| Shareholder Yield | 1.40% |
Peer Position
Against 10 similar companies, NHC has the 4th highest P/E and the 8th highest ROIC.
P/E RatioPeer median 20.5x
P/S RatioPeer median 1.5x
ROICPeer median 9.78%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +7.11%
Dividend YieldPeer median 0.00%
| P/E Ratio | 28.6x vs 20.5x median |
|---|---|
| P/S Ratio | 2.0x vs 1.5x median |
| ROIC | 8.08% vs 9.78% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +5.58% vs +7.11% median |
| Dividend Yield | 1.30% vs 0.00% median |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Overvalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About NHC
What is NHC's market cap?
National HealthCare has a market cap of $3.26B. Its enterprise value, which adds debt and subtracts cash, is $3.69B.
What is NHC's P/E ratio?
National HealthCare has a trailing P/E ratio of 28.6x.
How many shares of NHC are outstanding?
National HealthCare has 15.64M shares outstanding. The count is up 1.00% from a year earlier.
Does NHC pay a dividend?
Yes. National HealthCare pays $2.68 a share a year, a dividend yield of 1.30%.
How much debt does NHC have?
National HealthCare has $502.06M of total debt and $66.80M of cash and equivalents, a net debt position of $435.27M.
NHC pages: Overview, Dividends, Charting, Earnings, Financials, Statistics, Valuation, Competitors, Government Contracts